VI. FDG-PET as a biomarker in lymphoma: from qualitative to quantitative analysis

Authors

• Michel Meignan

  Corresponding author

  1. LYSA Imaging, Department of Nuclear Medicine, Henri Mondor University Hospital, Créteil, France

  • Correspondence to: Prof. Michel Meignan, LYSA Imaging, Department of Nuclear Medicine, Henri Mondor University Hospital, Créteil 94010, France.

    E-mail: michel.meignan@hmn.aphp.fr

  Search for more papers by this author